These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23131799)

  • 1. Solvent-free drug crystal engineering for drug nano- and micro suspensions.
    da Fonseca Antunes AB; De Geest BG; Vervaet C; Remon JP
    Eur J Pharm Sci; 2013 Jan; 48(1-2):121-9. PubMed ID: 23131799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.
    Verma S; Gokhale R; Burgess DJ
    Int J Pharm; 2009 Oct; 380(1-2):216-22. PubMed ID: 19596059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
    Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
    Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
    Mou D; Chen H; Wan J; Xu H; Yang X
    Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and drying of miconazole and itraconazole nanosuspensions.
    Cerdeira AM; Mazzotti M; Gander B
    Int J Pharm; 2013 Feb; 443(1-2):209-20. PubMed ID: 23291552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of fine solid-crystal suspension with enhanced solubility, stability, and aerosolization performance for dry powder inhalation.
    Lin L; Quan G; Peng T; Huang Z; Singh V; Lu M; Wu C
    Int J Pharm; 2017 Nov; 533(1):84-92. PubMed ID: 28903066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryogenic liquids, nanoparticles, and microencapsulation.
    Purvis T; Vaughn JM; Rogers TL; Chen X; Overhoff KA; Sinswat P; Hu J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2006 Oct; 324(1):43-50. PubMed ID: 16814968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast dissolution of poorly water soluble drugs from fluidized bed coated nanocomposites: Impact of carrier size.
    Azad M; Moreno J; Bilgili E; Davé R
    Int J Pharm; 2016 Nov; 513(1-2):319-331. PubMed ID: 27639622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.
    Singh SK; Srinivasan KK; Gowthamarajan K; Singare DS; Prakash D; Gaikwad NB
    Eur J Pharm Biopharm; 2011 Aug; 78(3):441-6. PubMed ID: 21439378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microparticle size control and glimepiride microencapsulation using spray congealing technology.
    Ilić I; Dreu R; Burjak M; Homar M; Kerc J; Srcic S
    Int J Pharm; 2009 Nov; 381(2):176-83. PubMed ID: 19446625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and characterization study of itraconazole-loaded microparticles.
    Segale L; Giovannelli L; Mannina P; Pattarino F
    Pharm Dev Technol; 2015 Mar; 20(2):153-8. PubMed ID: 24219826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with Naproxen and Cinnarizine.
    Kayaert P; Van den Mooter G
    Eur J Pharm Biopharm; 2012 Aug; 81(3):650-6. PubMed ID: 22579733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.
    Linn M; Collnot EM; Djuric D; Hempel K; Fabian E; Kolter K; Lehr CM
    Eur J Pharm Sci; 2012 Feb; 45(3):336-43. PubMed ID: 22172603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of stabilized itraconazole nanodispersions by using high-gravity technique.
    Zhang ZL; Le Y; Wang JX; Zhao H; Chen JF
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1512-20. PubMed ID: 22435399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach to produce drug nanosuspensions CO2-assisted effervescence to produce drug nanosuspensions.
    Han X; Wang M; Ma Z; Xue P; Wang Y
    Colloids Surf B Biointerfaces; 2016 Jul; 143():107-110. PubMed ID: 26998871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydration of an amphiphilic excipient, Gelucire 44/14.
    Svensson A; Neves C; Cabane B
    Int J Pharm; 2004 Aug; 281(1-2):107-18. PubMed ID: 15288348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
    Kocbek P; Baumgartner S; Kristl J
    Int J Pharm; 2006 Apr; 312(1-2):179-86. PubMed ID: 16469459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-sized crystalline drug production by milling technology.
    Moribe K; Ueda K; Limwikrant W; Higashi K; Yamamoto K
    Curr Pharm Des; 2013; 19(35):6246-58. PubMed ID: 23470002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement.
    Sanganwar GP; Sathigari S; Babu RJ; Gupta RB
    Eur J Pharm Sci; 2010 Jan; 39(1-3):164-74. PubMed ID: 19961931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.